<?xml version="1.0" encoding="UTF-8"?>
<p>The coronavirus disease 2019 (COVID-19) pandemic due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emergent threat to EHE. HIV positivity per se does not increase the risk of COVID-19 diagnosis, morbidity, or mortality, and some ARVs may even be protective [
 <xref rid="CIT0085" ref-type="bibr">85</xref>]; however, many PWH belong to demographic groups or have comorbidities that heighten the risk of infection, morbidity, and/or mortality due to COVID-19 [
 <xref rid="CIT0086" ref-type="bibr">86</xref>]. The pandemic has severely disrupted the healthcare infrastructure that PWH use, with as-yet unknown implications [
 <xref rid="CIT0087" ref-type="bibr">87</xref>]. Furthermore, it has overwhelmingly diverted the national and local resources, including those of the health departments in Texas and elsewhere, for the foreseeable future. Nevertheless, the pandemic provides an opportunity for expediting HIV-differentiated service delivery [
 <xref rid="CIT0088" ref-type="bibr">88</xref>].
</p>
